Welcome to Francis Academic Press

Academic Journal of Medicine & Health Sciences, 2025, 6(8); doi: 10.25236/AJMHS.2025.060807.

Study on the Mechanism of Acanthopanax Senticosus Polysaccharides Alleviating Anxiety- and Depression-like Behaviors in DSS-induced Colitis Mice

Author(s)

Sun Yufei, Wang Jiachen, Zhao Zhihao

Corresponding Author:
​Sun Yufei
Affiliation(s)

College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, 150040, China

Abstract

The purpose of this study is to investigate the alleviating effect and mechanism of Acanthopanax senticosus polysaccharides (ASP) on anxiety- and depression-like behaviors in mice with DSS-induced colitis. Mice were divided into the Control group, DSS group, ASP-L group, ASP-H group and mesalazine group. The effects were evaluated by observing general conditions, conducting behavioral tests and performing RT-qPCR detection. The results showed that mice in the DSS group exhibited colitis symptoms such as weight loss, diarrhea and hematochezia, accompanied by obvious anxiety- and depression-like behaviors. Meanwhile, the expressions of IL-6, IL-1β and TNF-α in colon tissues were increased, and the expression of BDNF in cerebral cortex was decreased. ASP could improve the above symptoms in a dose-dependent manner, reduce the levels of inflammatory factors and up-regulate the expression of BDNF, with the effect of high-dose ASP being similar to that of mesalazine. These findings indicate that ASP may alleviate colitis and its accompanying mental and behavioral abnormalities by inhibiting intestinal inflammation and regulating central nervous factors, providing experimental basis for the treatment of related diseases.

Keywords

Acanthopanax Senticosus Polysaccharides, DSS, Colitis, Anxiety, Depression, Inflammatory Factors, BDNF

Cite This Paper

Sun Yufei, Wang Jiachen, Zhao Zhihao. Study on the Mechanism of Acanthopanax Senticosus Polysaccharides Alleviating Anxiety- and Depression-like Behaviors in DSS-induced Colitis Mice. Academic Journal of Medicine & Health Sciences (2025), Vol. 6, Issue 8: 55-61. https://doi.org/10.25236/AJMHS.2025.060807.

References

[1] Rogler G, Singh A, Kavanaugh A, et al. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management[J]. Gastroenterology, 2021, 161(4):1118-1132.

[2] Ma J, Zhang J, Wang Y, et al. Modified Gegen Qinlian decoction ameliorates DSS-induced chronic colitis in mice by restoring the intestinal mucus barrier and inhibiting the activation of γδT17 cells[J]. Phytomedicine, 2023, 111:154660.

[3] Liang Q, Han D, Jiang J, et al. Extraction, structural characteristics, bioactivities and application of polysaccharides from Acanthopanax senticosus (Rupr. Maxim.) harms: A review[J]. Int J Biol Macromol, 2025, 299:139972.

[4] Bisgaard TH, Allin KH, Keefer L, et al. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment[J]. Nat Rev Gastroenterol Hepatol, 2022, 19(11):717-726.

[5] Ge L, Liu S, Li S, et al. Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut-brain communications[J]. Front Immunol, 2022, 13:1016578.

[6] Xue J, Su J, Wang X, et al. Eco-Friendly and Efficient Extraction of Polysaccharides from Acanthopanax senticosus by Ultrasound-Assisted Deep Eutectic Solvent[J]. Molecules, 2024, 29(5):942.

[7] Li X, Chen C, Leng A, et al. Advances in the Extraction, Purification, Structural Characteristics and Biological Activities of Eleutherococcus senticosus Polysaccharides: A Promising Medicinal and Edible Resource With Development Value[J]. Front Pharmacol, 2021, 12:753007.

[8] Zou L, Tian Y, Wang Y, et al. High-cholesterol diet promotes depression- and anxiety-like behaviors in mice by impact gut microbe and neuroinflammation[J]. J Affect Disord, 2023, 327:425-438.

[9] Liu P, Liu Z, Wang J, et al. Immunoregulatory role of the gut microbiota in inflammatory depression[J]. Nat Commun, 2024, 15(1):3003.

[10] Colucci-D'Amato L, Speranza L, Volpicelli F. Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer[J]. Int J Mol Sci, 2020, 21(20):7777.

[11] Albini M, Krawczun-Rygmaczewska A, Cesca F. Astrocytes and brain-derived neurotrophic factor (BDNF) [J]. Neurosci Res, 2023, 197:42-51.